Dietriche Jones
Family · Tupelo, MSNPI 1376724799
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (49.7%), consulting fees and education — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Viiv Healthcare Company at 58.1% of the total. Reporting peaked in 2022 at $2,383 and has fallen 87.1% since, to $307 in 2025. Among family clinicians in MS with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 135 payments — averaging $41.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$3K
- Gilead$387
- Mayne Pharma Commercial LLC$342
- Johnson & Johnson$180
- Astellas Pharma US Inc$176
- Theratechnologies Inc.$161
- plus $1K from 18 others
What the payments were for
- Consulting fees$2,73049%
- Food & beverage$2,78750%
- Education$942%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 30 | $3,262 |
| Gilead | 11 | $387 |
| Mayne Pharma Commercial LLC | 13 | $342 |
| Johnson & Johnson(2 entities) | 10 | $180 |
| Astellas Pharma US Inc | 9 | $176 |
| Theratechnologies Inc. | 8 | $161 |
| AbbVie | 7 | $157 |
| Daiichi Sankyo Inc. | 6 | $130 |
| Merck | 5 | $97 |
| Boehringer Ingelheim | 6 | $97 |
| Hologic Sales And Service, LLC | 3 | $80 |
| Organon | 3 | $73 |
| Shield Therapeutics Inc | 4 | $69 |
| Janssen Products, LP | 1 | $66 |
| Lilly USA, LLC | 3 | $60 |
| Exeltis, USA Inc. | 4 | $59 |
| Pfizer | 3 | $59 |
| Novo Nordisk | 3 | $53 |
| Ironwood Pharmaceuticals, Inc | 1 | $24 |
| Hikma Pharmaceuticals USA | 1 | $19 |
| Bayer | 1 | $17 |
| Abbott | 1 | $16 |
| BD | 1 | $15 |
| Millicent US Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DOVATO$2,730
- NEXTSTELLIS$113
- Biktarvy$111
How this compares
$5,612 in reported general payments places this provider in the 90th percentile of 3,007 family providers in Mississippi.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ValacyclovirValacyclovir Hcl | 16 | $485 |
| Metronidazole | 20 | $280 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 21 | $247 |
| Fluconazole | 13 | $112 |
Paid to pharmacies, not to this prescriber.
Other family in Tupelo
- Jessica EatonTupelo$25K
- Lisa SandersTupelo$16K
- Amanda RobinsonTupelo$15K
- Ashley HensonTupelo$12K
- Dodie McGeeRaymond$772K
- Gina BurgeJackson$237K
- Christy DavisJackson$208K
- Maranda EversollFlowood$197K
- Dana DelaskiJackson$158K
- Kristin CarrollJackson$158K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.